Effects of soluble epoxide hydrolase inhibitor on the expression of fatty acid synthase in peripheral blood mononuclear cell in patients with acute coronary syndrome

BACKGROUND: Researches have shown that soluble epoxide hydrolase inhibitors (sEHi) can protect against the development of atherosclerosis. Simultaneously, emerging evidences have implicated the association between fatty acid synthase (FAS) and acute coronary syndrome (ACS). We tested the hypothesis...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xuan, Du, Jian-qing, Xu, Dan-yan, Zhao, Shui-ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554480/
https://www.ncbi.nlm.nih.gov/pubmed/23305094
http://dx.doi.org/10.1186/1476-511X-12-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554480/
https://www.ncbi.nlm.nih.gov/pubmed/23305094
http://dx.doi.org/10.1186/1476-511X-12-3

Ejemplares similares